An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of uncertain source.
Several professionals said the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer laws, potentially leading to fines, legal action or prison.
Service Reaction and Material Removal
According to TikTok, the service has taken down problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also found groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.
Within minutes of entering one group, a seller shared contact information, where most purchases take place. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Details and Costs
Inside these communities, posts display black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant health risks”.
